Adjuvant chemotherapy with oxaliplatin and capecitabine versus follow-up after resection of colorectal liver metastases -randomized phase III study.

Trial Profile

Adjuvant chemotherapy with oxaliplatin and capecitabine versus follow-up after resection of colorectal liver metastases -randomized phase III study.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 29 Dec 2009

At a glance

  • Drugs Capecitabine (Primary) ; Oxaliplatin (Primary)
  • Indications Cancer metastases; Colorectal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Mar 2009 Additional lead trial centre and investigator identified as reported by ClinicalTrials.gov.
    • 05 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top